butylscopolammonium bromide has been researched along with plumbagin in 2 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (plumbagin) | Trials (plumbagin) | Recent Studies (post-2010) (plumbagin) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 537 | 0 | 346 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | plumbagin (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 2.77 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 2.46 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 6.3 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 0.7 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 3.1 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 6.3 | |
| Histone acetyltransferase p300 | Homo sapiens (human) | 2 | |
| Cytochrome P450 1B1 | Homo sapiens (human) | 6.15 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 0.06 | |
| 60 kDa chaperonin | Escherichia coli | 2.045 | |
| 10 kDa chaperonin | Escherichia coli | 2.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for butylscopolammonium bromide and plumbagin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |